Martin F. Schacker
Directeur Général chez Tetragenex Pharmaceuticals, Inc.
Profil
Martin F.
Schacker is currently the Chairman & Co-Chief Executive Officer at Tetragenex Pharmaceuticals, Inc. He was previously the Chairman & Chief Executive Officer at M.S.
Farrell & Co., Inc. from 1991 to 2001.
Prior to that, he was a Senior Vice President at Lehman Brothers Holdings Plc from 1982 to 1987 and at D.H.
Blair & Co. from 1987 to 1991.
Schacker received his undergraduate degree from Hofstra University in 1982.
Postes actifs de Martin F. Schacker
| Sociétés | Poste | Début |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Directeur Général | 05/02/2010 |
Anciens postes connus de Martin F. Schacker
| Sociétés | Poste | Fin |
|---|---|---|
| M.S. Farrell & Co., Inc. | Président | 02/02/2001 |
| D.H. Blair & Co. | Corporate Officer/Principal | 02/12/1991 |
Lehman Brothers Holdings Plc
 Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Corporate Officer/Principal | 02/05/1987 |
Formation de Martin F. Schacker
| Hofstra University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| M.S. Farrell & Co., Inc. | |
| D.H. Blair & Co. | |
Lehman Brothers Holdings Plc
Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Finance |
